DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20221915
Published: 2022-07-27

Oral itraconazole combined with local isoconazole in the treatment chronic candida vulvovaginitis

Mostafa Abdulla Elsayed

Abstract


Background: Chronic vulvovaginal candidiasis is a major problem and common with poor quality of life from itching and discharge and it is difficult to treat because fungi are slow growers.

Methods: Two hundred cases recruited from JAM clinic in Benha city, Egypt divided into two groups to study combination of oral itraconazole and local isoconazole in comparison with the use of local isoconazole only in chronic monilial vulvovaginitis and main outcome was relief of symptoms and signs with absent laboratory evidence of monilial infection by culture. Group one included 100 cases treated with combined oral itraconazole with three alternate days dose of local isoconazole (gynotrazonagen) and group two (local isoconazole only) included 100 cases treated with local isoconazole ovules on alternate days for 3 doses and week period.

Results: Regarding the cure rate there were 90 clinically cured rate in the combined group compared to 70 in the local treatment group with p value of 0.0004 which was a very high statistically significant difference. Clinical cure included alleviation of the symptoms of discharge dysuria dyspareunia burning itching with also by clinical examination cure and disappearance of redness erythema edema fissures with absent pseudomycelia by microscopic examination. Usually, a symptom score of less than 2 is a positive one. Regarding the laboratory cure which means absent or negative candida culture on Sabaraud agar medium there were a laboratory cure rate of 84 out of 100 in the combined treatment group compared to 65 out of 100 in the local treatment group with p value of 0.002 and a high statistically significant difference.

Conclusions: Oral itraconazole combined with local isoconazole is highly effective in treating chronic monilial vulvovaginitis.


Keywords


Candida vulvovaginitis, Isoconazole, Itraconazole

Full Text:

PDF

References


Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152:924-35.

Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905-27.

Eschenauer GA, Nguyen MH, Clancy CJ. Is fluconazole or an echinocandin the agent of choice for candidemia. Ann Pharmacother. 2015;49(9):1068-74.

Fan S, Liu X, Liang Y. Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis. Gynecol Obstet Invest. 2015;80(2):113-8.

Sekhavat L, Tabatabaii A, Tezerjani FZ. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. J Infect Public Health. 2011;4(4):195-9.

Zhou X, Li T, Fan S, Zhu Y, Liu X, Guo X, et al. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses. 2016;59(7):419-28.

Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340-5.

Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med Mycol. 2011;49(1):16-25.

Fardiazar Z, Ronaci F, Torab R, Goldust M. Vulvovaginitis candidiasis recurrence during pregnancy. Pak J Biol Sci. 2012;15(8):399-402.

Van der Meijden WI, van der Hoek JC, Staal HJ, van Joost T, Stolz E. Double-blind comparison of 200-mg ketoconazole oral tablets and 1200-mg miconazole vaginal capsule in the treatment of vaginal candidosis. Eur J Obstet Gynecol Reprod Biol. 1986;22(3):133-8.

Kutzer E, Oittner R, Leodolter S, Brammer KW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol. 1988;29(4):305-13.

Eschenauer GA, Nguyen MH, Clancy CJ. Is fluconazole or an echinocandin the agent of choice for candidemia. Ann Pharmacother. 2015;49(9):1068-74.

Cauwenbergh G. Itraconazole: the first orally active antifungal for single-day treatment of vaginal candidosis. Curr Ther Res. 1987;41:10-4.

Woolley PD. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract. 1995;49:65-6.

Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med. 1992;68:36-8.